Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 1 open-label PK study of ON 001 in healthy elderly women
NL-OMON37203Phase 1Active, not recruiting
- Sponsor
- OrgaNext Research
- Start
- Sep 2012
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of nandrolone and vitamin d in hip fracture, sponsored by OrgaNext Research. Primary endpoint: Pharmacokinetics. Started Sep 2012; status: active, not recruiting.
02
Drugs
nandrolonevitamin d
03
Conditions
hip fracture
Beyond the preview
Go deeper on NL-OMON37203.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON37203.